Laboratory

Alimera announces option of ILUVIEN in U.K. For chronic DME treatment Alimera Sciences, Inc. In addition, Alimera Sciences has recently submitted a simple Patient Access Scheme to the United Kingdom's National Ins...

Patients treated with crizotinib also acquired a significantly higher delay in the worsening of lung-cancer symptoms than did patients treated with chemotherapy . A significantly higher improvement from baseline was o...